|
|||
| |||||||||||||||||||||||||||||||||||||||||
Dr. Donald S. Kaufman: A 77-year-old man with a history of transitional-cell carcinoma of the right ureter was seen in the multidisciplinary urologic oncology clinic of this hospital because of a mass in the left ureter and cytologic evaluations of urine specimens that were positive for transitional-cell carcinoma.
Eight years earlier, after two episodes of gross hematuria, a diagnosis of transitional-cell carcinoma of the right renal pelvis was made at another hospital. Right nephroureterectomy was performed; pathological examination revealed a transitional-cell carcinoma of the renal pelvis, stage T3, extending through the muscularis into the peripelvic fat and renal parenchyma, with
Discussion of Management
Pathological Discussion
Discussion of Management
Pathological Discussion
Anatomical Diagnoses
Source Information
From the Hematology–Oncology Division, Department of Medicine (D.S.K.), and the Departments of Urology (W.S.M.), Radiology (M.G.H.), and Pathology (C.-L.W.), Massachusetts General Hospital; and the Departments of Medicine (D.S.K.), Urology (W.S.M.), Radiology (M.G.H.), and Pathology (C.-L.W.), Harvard Medical School.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved. |